IPO Issue Details
Issue Price / Price Band₹90 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size1,600 Shares per Lot
Total Issue Size27,60,000 shares (aggregating up to ₹24.84 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformBSE SME
IPO TypeSME
Subscription OpenWed, 24 May 2023
Subscription CloseFri, 26 May 2023
Anchor AllotmentTue, 23 May 2023
Basis of AllotmentWed, 31 May 2023
Initiation of RefundsThu, 01 Jun 2023
Credit of Shares to DematFri, 02 Jun 2023
Listing DateMon, 05 Jun 2023
UPI Mandate Deadline2023-05-26
Application & Investment Details
Retail — Min (1 Lots)₹1,44,000 — 1,600 shares
Retail — Max (13 Lots)₹1,872,000 (13 Lots)
HNI — Min (2 Lots)₹2,88,000 — 3,200 shares
EPS (Pre-IPO)₹10.26
P/E Ratio (Pre-IPO)12.28x
Net Offer to Public26,16,000 shares (aggregating up to ₹23.54 Cr)
Reserved for Market Maker1,44,000 shares (aggregating up to ₹1.30 Cr)
Pre-IPO Promoter Holding76,80,000 shares
Post-IPO Promoter Holding1,04,40,000 shares
About Hemant Surgical Industries Ltd.
Incorporated in 1989, Hemant Surgical Industries Limited is engaged in the business of manufacturing, importing, and assembling. Also, the company markets a comprehensive portfolio of medical equipments and disposables.The wide spectrum of equipments and disposables offered by the company includes:Renal CareCardiovascular diseaseRespiratory diseaseCritical Care and RadiologySurgical disposablesThe products processed in the assembly units of the company are imported from countries like: Japan, China France, and Australia.Hemant Surgical Industries presently has one manufacturing unit and two assembly units. The first Manufacturing Unit is situated at Achad Industrial Estate. The company started its operations of importing and marketing of medical disposables through this unit in 1999. The other two assembling units are located at Atgaon and Bhiwandi, respectively. These two assembling units undertake the assembling of medical products and devices.The company's facilities are ISO 9001:2015 and ISO 13485:2016 certified. They have a fully equipped quality control department with experienced and qualified staff to facilitate smooth manufacturing and assembly line processes.
Objects of the Issue
Hemant Surgical Industries Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
Funding Capital Expenditure towards installation of additional plant and machinery
7.51
2
Funding to meet working capital requirements
10.00
3
General Corporate Purpose
3.14
Shareholding & Lock-in
Pre-IPO Promoter Holding
76,80,000 shares
Post-IPO Promoter Holding
1,04,40,000 shares